Predicted expression of genes involved in the thiopurine metabolic pathway and azathioprine discontinuation due to myelotoxicity

MLA

Laura L. Daniel, et al. “Predicted Expression of Genes Involved in the Thiopurine Metabolic Pathway and Azathioprine Discontinuation Due to Myelotoxicity.” Clinical and Translational Science, vol. 15, no. 4, Apr. 2022, pp. 859–65. EBSCOhost, https://doi.org/10.1111/cts.13243.

APA

Laura L. Daniel, Alyson L. Dickson, Jacy T. Zanussi, Tyne W. Miller‐Fleming, Peter S. Straub, Wei‐Qi Wei, W. Dale Plummer, William D. Dupont, Ge Liu, Prathima Anandi, Tyler S. Reese, Kelly A. Birdwell, Vivian K. Kawai, Adriana M. Hung, Nancy J. Cox, QiPing Feng, C. Michael Stein, & Cecilia P. Chung. (2022). Predicted expression of genes involved in the thiopurine metabolic pathway and azathioprine discontinuation due to myelotoxicity. Clinical and Translational Science, 15(4), 859–865. https://doi.org/10.1111/cts.13243

Chicago

Laura L. Daniel, Alyson L. Dickson, Jacy T. Zanussi, Tyne W. Miller‐Fleming, Peter S. Straub, Wei‐Qi Wei, W. Dale Plummer, et al. 2022. “Predicted Expression of Genes Involved in the Thiopurine Metabolic Pathway and Azathioprine Discontinuation Due to Myelotoxicity.” Clinical and Translational Science 15 (4): 859–65. doi:10.1111/cts.13243.